profit from every SEK 100 of sales.
SEK 0SEK 100
Synsam
SEK 58.90+0.68% today
-9.7% in 1 year
1-year low SEK 50.801-year high SEK 70.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay SEK 18.18 for every SEK 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Synsam sold, what it kept, and what it did with the cash.
Sales went from SEK 5.35 billion in 2022 to SEK 7.20 billion in 2025, with SEK 454 million of profit last year.
SalesProfit
Synsam handed back 49% of the cash it generated last year.
Buybacks SEK 206MSEK 260M
Free cash flow 2025SEK 949M
Bought back its own sharesSEK 206M
Paid as dividendsSEK 260M
Cash vs. debtSEK 600M vs. SEK 3.6B
Synsam vs. similar companies
Synsam grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from SEK 100 of sales | Sales growth a year | Price per SEK 1 of profit |
|---|---|---|---|
| Synsam | 18.2× · Fair price | ||
 Intuitive Surgical | 55.9× · Expensive | ||
 EssilorLuxottica Société anonyme | 37.7× · Expensive | ||
 Becton, Dickinson and | 34.9× · Expensive | ||
 Medline | 46.2× · Expensive |
AI analysis
An AI analyst reads Synsam's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 5,349 | 5,984 | 6,523 | 7,200 | |
| 4,070 | 4,537 | 4,932 | 5,379 | |
| 552 | 696 | 820 | 861 | |
| 1,182 | 1,346 | 1,477 | 1,598 | |
| 328 | 311 | 366 | 454 | |
| 2.19 | 2.08 | 2.48 | 3.14 | |
| 76.1% | 75.8% | 75.6% | 74.7% | |
| 10.3% | 11.6% | 12.6% | 12.0% | |
| 6.1% | 5.2% | 5.6% | 6.3% |
Balance sheet
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 8,019 | 8,036 | 8,244 | 7,945 |
| Cash | 444 | 582 | 420 | 600 |
| Total debt | 3,439 | 3,301 | 3,464 | 3,557 |
| Total liabilities | 5,435 | 5,520 | 5,689 | 5,509 |
| 2,584 | 2,516 | 2,555 | 2,436 | |
| 150 | 149 | 148 | 144 | |
| 6.8% | 8.2% | 9.2% | 10.2% | |
| 12.7% | 12.4% | 14.3% | 18.6% |
Cash flow
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 690 | 1,150 | 933 | 1,266 | |
| 382 | 248 | 377 | 317 | |
| 308 | 902 | 556 | 949 | |
| Dividends paid | 255 | 253 | 266 | 260 |
| 47 | 30 | 85 | 206 | |
| – | – | – | – |
Valuation
- 18.2×
- –
- 1.42
- 3.3×
- 1.1×
- 8.7×
- 7.0×
- 11.5%
- 5.5%
- 3.2%
Profitability
- 74.7%
- 12.0%
- 6.3%
- –
- 10.2%
- 8.6%
- –
- –
- –
- –
Growth
- +10.4%
- +12.8%
- –
- –
- −1.2%
Financial health
- 1.9×
- 1.46
- –
- 4.3×
- 1.08
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 27%of 948
Top 43%of 871
Top 27%of 560
Bottom 47%of 868
Top 5%of 985
3.2%of the share price, paid each year
On $1,000 invested$32a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
57.3% of its profit
Room to growStretchedMore than it earns: 27.4%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
62Pass
Benjamin Graham
46No pass
Philip Fisher
66Pass
Peter Lynch
51No pass
Joel Greenblatt
37No pass
Charlie Munger
44No pass
Terry Smith
48No pass
Questions about Synsam
Is Synsam a good stock to buy?
A business with weak numbers at a fair price. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Synsam AI analysis
What does Synsam do?
Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It is in Medical Instruments & Supplies, based in Stockholm, Sweden, with 5,400 employees.
Does Synsam pay a dividend?
Yes. At today's price the dividend is 3.2% a year, about 57% of its yearly profit. In 2025 it paid out SEK 260 million in dividends.
Is Synsam stock halal?
No. Synsam does not pass our halal screen: its debt is 43% of its market value, at or above the 33% limit. How we check
How has Synsam stock done over the past year?
Down 9.7% over the past twelve months, to SEK 58.90. It traded between SEK 50.80 and SEK 70.00 and is 15.9% below its high.
Who are Synsam's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Synsam's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.